{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:50:06Z","timestamp":1767016206575,"version":"3.40.3"},"reference-count":88,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2013,11,30]],"date-time":"2013-11-30T00:00:00Z","timestamp":1385769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Portuguesa de Pneumologia"],"published-print":{"date-parts":[[2013,11,30]]},"DOI":"10.1016\/j.rppneu.2013.03.006","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T08:31:06Z","timestamp":1373531466000},"page":"266-275","source":"Crossref","is-referenced-by-count":9,"title":["New advances in the therapy of non-cystic fibrosis bronchiectasis"],"prefix":"10.1080","volume":"19","author":[{"given":"A.","family":"Amorim","sequence":"first","affiliation":[{"name":"Pneumology Department, Centro Hospitalar S\u00e3o Jo\u00e3o, EPE, Faculty of Medicine, University of Porto","place":["Porto, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gamboa","sequence":"additional","affiliation":[{"name":"Pneumology Department, Centro Hospitalar e Universit\u00e1rio de Coimbra-Hospitais da Universidade de Coimbra, EPE","place":["Coimbra, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Pneumology Department, Centro Hospitalar Santa Maria, Faculty of Medicine, University of Lisbon","place":["Lisbon, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"e_1_3_1_2_1","first-page":"52","article-title":"Bronchiectasis","author":"Floto R.A.","year":"2011","unstructured":"R.A.Floto, C.S.Haworth Bronchiectasis. Eur Respir Mon. 2011:52","journal-title":"Eur Respir Mon"},{"key":"e_1_3_1_3_1","first-page":"33","article-title":"Bronchiectasis","author":"Metersky M.L.","year":"2012","unstructured":"M.L.Metersky, A.E.O\u2019Donnel Bronchiectasis. Clin Chest Med. 2012:33","journal-title":"Clin Chest Med"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.136119"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1157\/13128330"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2012.03.001"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0412"},{"key":"e_1_3_1_8_1","first-page":"1176","article-title":"Mucoactive agents for airway mucus hypersecretory diseases","volume":"52","author":"Rogers D.","year":"2007","unstructured":"D.Rogers Mucoactive agents for airway mucus hypersecretory diseases. Respir Care. 2007; 52: 1176\u20131198","journal-title":"Respir Care"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00057003"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2005.00659.x"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1183\/18106838.0604.353"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2012.02189.x"},{"key":"e_1_3_1_13_1","unstructured":"Bronchitol\u00ae Pharmaxis Pharmaceuticals Ltd. European Medicines Agency. 2013www.ema.europa.eu"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.2.414"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00187510"},{"key":"e_1_3_1_16_1","first-page":"A3221","article-title":"A randomized placebo-controlled trial of inhaled mannitol in patients with bronchiectasis","volume":"179","author":"Bilton D.","year":"2009","unstructured":"D.Bilton, E.Daviskas, A.Jacques, S.D.Anderson, B.Charlton A randomized placebo-controlled trial of inhaled mannitol in patients with bronchiectasis. Am J Respir Crit Care Med. 2009; 179: A3221","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_1_17_1","unstructured":"A Phase III Multicenter Randomized Parallel Group Controlled Double Blind Study to Investigate the Safety and Efficacy of Inhaled Mannitol Over 12 Months in the Treatment of Bronchiectasis. 2013http:\/\/www.clinicaltrials.gov\/NCT00669331"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043900"},{"key":"e_1_3_1_19_1","first-page":"CD001506","article-title":"Nebulised hypertonic saline for cystic fibrosis","volume":"2","author":"Wark P.","year":"2009","unstructured":"P.Wark, V.M.McDonld Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev. 2009; 2: CD001506","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.05.006"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.07.019"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.12.021"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.12.016"},{"key":"e_1_3_1_24_1","first-page":"1176","article-title":"Mucoactive agents for airway mucus hypersecretory diseases","volume":"52","author":"Rogers D.F.","year":"2007","unstructured":"D.F.Rogers Mucoactive agents for airway mucus hypersecretory diseases. Respir Care. 2007; 52: 1176\u20131197","journal-title":"Respir Care"},{"key":"e_1_3_1_25_1","first-page":"CD001289","article-title":"Mucolytics for bronchiectasis","volume":"1","author":"Crockett A.J.","year":"2001","unstructured":"A.J.Crockett, J.M.Cranston, K.M.Latimer, K.M.Latiner Mucolytics for bronchiectasis. Cochrane Database Syst Rev. 2001; 1: CD001289","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.5.1329"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0776"},{"key":"e_1_3_1_28_1","first-page":"6","article-title":"Inflammation: a two-edged sword\u2014the model of bronchiectasis","volume":"147","author":"Cole P.J.","year":"1986","unstructured":"P.J.Cole Inflammation: a two-edged sword\u2014the model of bronchiectasis. Eur J Respir Dis Suppl. 1986; 147: 6\u201315","journal-title":"Eur J Respir Dis Suppl"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.9.2105083"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1159\/000320319"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000320320"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.08.001"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1579-2129(10)70060-4"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10050994"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.13236199"},{"key":"e_1_3_1_36_1","first-page":"540","article-title":"Prophylactic antibiotic treatment of bronchiectasis with azithromycin","volume":"59","author":"Davies G.","year":"2004","unstructured":"G.Davies, R.Wilson Prophylactic antibiotic treatment of bronchiectasis with azithromycin. Thorax. 2004; 59: 540\u2013541","journal-title":"Thorax"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.2165\/00151829-200504020-00005"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2006.00708.x"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.06.005"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.01.009"},{"issue":"54","key":"e_1_3_1_41_1","first-page":"333s","article-title":"Long-term azithromycin treatment: a randomized placebo-controlled trial in non-CF bronchiectasis; results from the BAT trial","volume":"36","author":"Alternburg J.","year":"2011","unstructured":"J.Alternburg, C.de Graaff, T.van der Werf, W.G.Boersma Long-term azithromycin treatment: a randomized placebo-controlled trial in non-CF bronchiectasis; results from the BAT trial. Eur Respir J. 2011; 36(Suppl. 54):333s","journal-title":"Eur Respir J"},{"issue":"1","key":"e_1_3_1_42_1","first-page":"A68624","article-title":"The Bronchiectasis and Low-dose Erythromycin Study (BLESS)","volume":"185","author":"Serisier D.J.","year":"2012","unstructured":"D.J.Serisier, S.D.Bowler, M.McGuckin, A.Chen, R.Lourie, M.L.Martin The Bronchiectasis and Low-dose Erythromycin Study (BLESS). Am J Respir Crit Care Med. 2012; 185(May (1 Meeting Abstracts)):A68624","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60953-2"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbr.2011.06.003"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2010.tb03949.x"},{"key":"e_1_3_1_46_1","first-page":"CD000996","article-title":"Inhaled steroids for bronchiectasis","volume":"1","author":"Kapur N.","year":"2009","unstructured":"N.Kapur, S.Bell, J.Kolbe, A.B.Chang Inhaled steroids for bronchiectasis. Cochrane Database Syst Rev. 2009; 1: CD000996","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0180"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503303321303"},{"key":"e_1_3_1_49_1","first-page":"CD001505","article-title":"Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis","volume":"4","author":"Lands L.C.","year":"2007","unstructured":"L.C.Lands, S.Stanojevic Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Cochrane Database Syst Rev. 2007; 4: CD001505","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_50_1","first-page":"CD006427","article-title":"Oral non steroid anti-inflammatories for children and adults with bronchiectasis","volume":"4","author":"Kapur N.","year":"2007","unstructured":"N.Kapur, A.B.Chang Oral non steroid anti-inflammatories for children and adults with bronchiectasis. Cochrane Database Syst Rev. 2007; 4: CD006427","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_51_1","first-page":"CD007525","article-title":"Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis","volume":"4","author":"Pizzutto S.J.","year":"2010","unstructured":"S.J.Pizzutto, J.W.Upham, S.T.Yerkovich, A.B.Chang Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis. Cochrane Database Syst Rev. 2010; 4: CD007525","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.06.004"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.12.7657"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.6.1673"},{"key":"e_1_3_1_55_1","unstructured":"Atorvastatin in bronchiectasis in patients with Pseudomonas aeruginosa. 2013 http:\/\/www.clinicaltrials.gov\/NCT01299194"},{"key":"e_1_3_1_56_1","unstructured":"A trial of atorvastatin as an anti-inflammatory agent in non-cystic fibrosis bronchiectasis. 2013 http:\/\/www.clinicaltrials.gov\/NCT01299181"},{"key":"e_1_3_1_57_1","first-page":"CD002174","article-title":"Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis","author":"Corless J.A.","year":"2000","unstructured":"J.A.Corless, C.J.Warburton Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database Syst Rev. 2000:CD002174","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_58_1","first-page":"CD002734","article-title":"Oral methylxanthines for bronchiectasis","author":"Steele K.","year":"2001","unstructured":"K.Steele, M.Greenstone Oral methylxanthines for bronchiectasis. Cochrane Database Syst Rev. 2001:CD002734","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_59_1","unstructured":"The effect of theophylline in the treatment of bronchiectasis. 2013 http:\/\/www.clinicaltrials.gov\/NCT01684683"},{"key":"e_1_3_1_60_1","unstructured":"The role of theophylline plus low-dose formoterol-budesonide in treatment of bronchiectasis. ClinicalTrials.gov. Trial identifier: NCT01769898."},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2005.01217.x"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.1.15"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.4.9906120"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.11.935"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2003.00101.x"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.011577"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.14613409"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200408-1044SO"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.008037"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl482"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-2896(01)75101-0"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.14512069"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.5.1503"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra012519"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0490"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.114.6.1594"},{"key":"e_1_3_1_77_1","first-page":"CD001392","article-title":"Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis","author":"Wood D.M.","year":"2006","unstructured":"D.M.Wood, A.R.Smyth Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev. 2006:CD001392","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.9.4480-4485.2005"},{"key":"e_1_3_1_79_1","first-page":"CD001392","article-title":"Prolonged antibiotics for purulent bronchiectasis in children and adults","author":"Evans D.J.","year":"2007","unstructured":"D.J.Evans, A.L.Bara, M.Greenstone Prolonged antibiotics for purulent bronchiectasis in children and adults. Cochrane Database Syst Rev. 2007:CD001392","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_80_1","first-page":"119","article-title":"Utilidad de los antibi\u00f3ticos inalados: m\u00e1s all\u00e1 de la fibrosis qu\u00edstica","volume":"6","author":"Lezana V.S.","year":"2011","unstructured":"V.S.Lezana, J.C.Arancibia Utilidad de los antibi\u00f3ticos inalados: m\u00e1s all\u00e1 de la fibrosis qu\u00edstica. Neumol Pediatr. 2011; 6: 119\u2013122","journal-title":"Neumol Pediatr"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.2.9910086"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201005-0756OC"},{"key":"e_1_3_1_83_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.3_suppl.114S"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E099"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.4.1420"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2007.01404.x"},{"key":"e_1_3_1_87_1","first-page":"A3214","article-title":"Inhaled liposomal ciprofloxacin hydrochloride significantly reduces sputum Pseudomonas aeruginosa density in CF and non-CF bronchiectasis","volume":"179","author":"Bilton D.","year":"2009","unstructured":"D.Bilton, P.Bruinenberg, B.Otulana, R.Morishige, J.Blanchard, A.DeSoyza, et al. Inhaled liposomal ciprofloxacin hydrochloride significantly reduces sputum Pseudomonas aeruginosa density in CF and non-CF bronchiectasis. Am J Respir Crit Care Med. 2009; 179: A3214","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2011.06.003"},{"key":"e_1_3_1_89_1","first-page":"143","article-title":"Tratamiento de las bronchiectasias no fibrosis qu\u00edstica en fase estable","volume":"18","author":"Vaquero Barrios J.M.","year":"2006","unstructured":"J.M.Vaquero Barrios, B.M.Bueno, L.M.Cabello, C.L.Entrenas, C.L.Mu\u00f1oz Tratamiento de las bronchiectasias no fibrosis qu\u00edstica en fase estable. Neumosur. 2006; 18: 143\u2013150","journal-title":"Neumosur"}],"container-title":["Revista Portuguesa de Pneumologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0873215913000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0873215913000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1016\/j.rppneu.2013.03.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:36:35Z","timestamp":1743208595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1016\/j.rppneu.2013.03.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,30]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11,30]]}},"alternative-id":["10.1016\/j.rppneu.2013.03.006"],"URL":"https:\/\/doi.org\/10.1016\/j.rppneu.2013.03.006","relation":{},"ISSN":["0873-2159"],"issn-type":[{"type":"electronic","value":"0873-2159"}],"subject":[],"published":{"date-parts":[[2013,11,30]]}}}